EU ok to marketing the Moderna vaccine

(ANSA) - BRUSSELS, JAN 06 - The European Commission has "granted a conditional marketing authorization for the Covid-19 vaccine developed by Moderna, the second Covid-19 vaccine authorized in the EU". This was reported by the Community executive in a note. "This authorization follows a positive scientific recommendation based on a thorough evaluation of the safety, efficacy and quality of the vaccine by the European Medicines Agency (EMA) and is approved by the Member States." "With the Moderna vaccine, the second now authorized in the EU, we will have another 160 million doses", commented the president of the European Commission, Ursula von der Leyen. "More vaccines will arrive. Europe has secured" in all "up to two billion doses of potential Covid-19 vaccines," he added, ensuring that vaccines will be "more than enough, safe and effective, to protect all Europeans" . (HANDLE).